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Abstract. Recent studies have indicated that the hematopoi-
etic stem/progenitor cell (HSPC) niche, consisting of two 
major crucial components, namely osteoblasts (OBs) and 
mesenchymal stromal cells (MSCs), is responsible for the fate 
of HSPCs. Thus, closely mimicking the HSPC niche ex vivo 
may be an efficient strategy with which to develop new culture 
strategies to specifically regulate the balance between HSPC 
self-renewal and proliferation. The aim of this study was to 
establish a novel HSPC three-dimensional culture system by 
co-culturing bone marrow-derived MSCs and OBs differenti-
ated from MSCs without any cytokines as feeder cells and 
applying bio-derived bone from human femoral metaphyseal 
portion as the scaffold. Scanning electron microscopy revealed 
the excellent biocompatibility of bio-derived bone with bone 
marrow-derived MSCs and OBs differentiated from MSCs. 
Western blot analysis revealed that many cytokines, which play 
key roles in HSPC regulation, were comprehensively secreted, 
while ELISA revealed that extracellular matrix molecules 
were also highly expressed. Hoechst 33342/propidium iodide 
fluorescence staining proved that our system could be used to 
supply a long-term culture of HSPCs. Flow cytometric analysis 
and qPCR of p21 expression demonstrated that our system 
significantly promoted the self-renewal and ex vivo expansion 
of HSPCs. Colony-forming unit (CFU) and long-term culture-
initiating cell (LTC-IC) assays confirmed that our system has 
the ability for both the expansion of CD34+ hematopoietic stem 
cells (HPCs) and the maintenance of a primitive cell subpopu-
lation of HSCs. The severe-combined immunodeficient mouse 
repopulating cell assay revealed the promoting effects of our 
system on the expansion of long-term primitive transplantable 
HSCs. In conclusion, our system may be a more comprehensive 
and balanced system which not only promotes the self-renewal 
and ex vivo expansion of HSPCs, but also maintains primitive 
HPCs with superior phenotypic and functional attributes.
Introduction
Hematopoietic stem cells (HSCs) are defined by their ability 
to generate all cells of the hematopoietic system. The stem cell 
niche provides a specific microenvironment for HSCs to reside, 
and is responsible for their fate in terms of quiescence, self-
renewal and differentiation (1). Recent studies have clarified the 
role of the marrow microenvironment in the pathogenesis of 
hematologic tumors. It has been reported that the identification 
of target molecules can be exploited to eradicate the leukemic 
stem cells from the niche (2,3). Modern hematopoietic stem/
progenitor cell (HSPCs) culture systems that closely mimic 
marrow physiology, can provide an experimental tool with 
which to understand the niche-mediated regulation of HSCs, 
under both physiological and diseased conditions (4). The 
latter may potentially help to design and develop novel thera-
peutic strategies to target the HSC niche. In addition, during 
the past three decades, HSC transplantation has become a 
well-established treatment for hematologic malignancies and 
non-malignant disorders. To improve the clinical outcome of 
autologous and allogeneic HSC transplantation, many study 
groups are focusing on the ex vivo expansion of HSCs, particu-
larly for those cases in which the graft is of limited size, such 
as HSCs from cord blood (5-7). However, the expansion of 
HSCs in vitro is difficult to be achieved due to known stem 
cell characteristics. Although the contribution of conventional 
hematopoietic culture systems to the knowledge of human HSC 
biology is unquestionable, these existing HSC culture systems 
cannot meet the requirements of the clinical application. 
Therefore it is necessary to constantly improve ex vivo experi-
mental systems to closely resemble their in vivo counterparts.
HSCs are regulated by intrinsic mechanisms and extrinsic 
signals mediated via specialized microenvironments known as 
‘niches’. The self-renewal and differentiation ability of HSCs 
are regulated by two major elements: endothelial and vascular 
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regulatory elements. In addition, the osteoblastic niche local-
ized at the inner surface of the bone cavity has been recognized 
as the main regulator of HSC fate and serves as a reservoir for 
long-term HSC storage in a quiescent state (8,9). The deletion of 
the gene Dicer expressed specifically in osteo-progenitors and 
immature osteoblasts (OBs), has been shown to affect hemato-
poiesis, indicating the involvement of a precise cell group within 
osteo-lineage cells in HSC maintenance (10). Taichman et al 
demonstrated that the in vitro culture of human bone marrow 
CD34+ cells with human OBs supported a 3-4-fold expansion 
of long-term culture-initiating cells in vitro (11). On the other 
hand, the vascular niche predominantly consists of the bone 
marrow sinusoidal endothelial cells, which are a part of the 
vascular system, and perivascular cells which surround the 
bone marrow vasculature, known as mesenchymal stem cells 
or mesenchymal stromal cells (MSCs) (12-15). Bone marrow-
derived stromal cells (BMSCs), from which OBs differentiate, 
possess the properties and functions of niche cells: namely 
CXC chemokine ligand 12 (CXCL12)-abundant reticular 
cells (CAR cells) (16) and Nestin+ MSCs. It has been reported 
that purified HSCs specifically home to Nestin+ MSCs in the 
bone marrow of irradiated mice and Nestin+ cell depletion 
results in a significantly compromised homing process (17). 
BMSCs have been shown to regulate the proliferation of 
HSCs rather than quiescence and support HSC maintenance 
and engraftment (17). Furthermore, BMSCs are characterized 
by their multi-differentiation potential. Our previous study 
demonstrated that OBs differentiated from BMSCs supported 
the maintenance and multipotency of HSPCs from umbilical 
cord blood in a 2D-culture system (18), suggesting that MSCs 
and OBs are suitable candidates with wich to build a novel HSP 
culture system.
In vitro HSC research is commonly carried out by 
culturing cells as monolayers using conventional tissue culture 
techniques. Although the contribution of conventional hemato-
poietic culture systems to the knowledge of human HSC biology 
is unquestionable, they lacked the three-dimensional (3D) 
architecture, thus failing to mimic the in vivo HSC niche, 
described as a three-dimensional microenvironment within 
the subendosteal region of bone marrow (1-3). In recent years, 
in vitro 3D-cultures of HSPCs have been shown to obviously 
be superior to bi-dimensional (2D) culture, which consists of 
HSPCs plus either sole MSCs or OBs, or both (10,19,20). These 
findings imply that a 3D architecture is important to mimic 
physiological conditions ex vivo.
Bone marrow is located in both long bones (e.g., femur) 
and flat bones (e.g., calvaria); however, bio-derived bone scaf-
folds (BDBS) which are made from human femurs can preserve 
the natural spongy architecture of trabecular bones and more 
closely mimic the HSC niche in vivo. In our previous study, we 
utilized OBs and BDBS to create a 3D culture system, which 
was primarily demonstrated to support the maintenance and 
expansion of HSPCs in vitro, and this system was obviously 
superior to 2D culture systems (21). Taking into consideration 
the deep understanding of the HSC niche, in the present study, 
we used a mixture of MSCs and OBs differentiated from 
BMSCs and BDBS to improve our 3D-Mix culture system and 
to explore their synergized function on the BDBS, illustrating 
that its features can more closely mimic those of the HSC niche. 
Our data demonstrate that the 3D-Mix culture system has some 
features more similar to those of the HSC niche in supporting 
the maintenance and expansion of HSPCs in vitro.
Materials and methods
Preparation of BDBS. The BDBS characterized with respect 
to natural porosity, pore size and minerals were made from 
the human skeleton and were manufactured by the Division of 
Stem Cell and Tissue Engineering (Laboratory of Biotecherapy, 
Sichuan University, Chengdu, China). The preparation of 
BDBS involved a process through which a series of physical 
and chemical procedures were performed to drastically wipe 
off the main antigens, such as cells and lipoproteins, apart from 
bone morphogenetic protein, collagen and salinity (22), which 
included degreasing, partial deproteinization, decalcification 
and extensive washing with distilled water. Finally, the BDBS 
were lyophilized and sterilized by 60Co gamma-ray irradiation 
(20-25x103 Gy) before being stored at 4˚C. The human BDBS 
were cut into sections (1.0x0.5x0.5 cm) in order to fit into wells 
of 24-well plates, and soaked in neonatal bovine serum for 
6 h. They were then soaked in Dulbecco's modified Eagle's 
medium (DMEM) with 10% neonatal bovine serum again for 
12 h before being used. The morphology of the BDBS was 
characterized by scanning electron microscopy.
Isolation and culture of human BMSCs. Heparinized human 
bone marrow cells were obtained from the posterior iliac crest 
of healthy volunteers with informed consent in accordance 
with the Declaration of Helsinki and following the approval 
of the Institutional Review Board of Sichuan Provincial 
Hospital. Bone marrow mononuclear cells (MNCs) were 
isolated after Ficoll-Hypaque (Sigma Diagnostics, St. Louis, 
MO, USA) gradient centrifugation at 400 x g for 30 min 
and plated in 25 cm2 cell culture flasks with expansion 
medium containing L-DMEM (Gibco Life Technologies, 
Paisley, UK), 10% fetal bovine serum (FBS; Gibco-BRL, 
Grand Island, NY, USA), 100 U/ml penicillin, 100 µg/ml 
streptomycin, 0.29 mg/ml L-glutamine and 3 mg/ml HEPES 
buffer (R&D Systems, Minneapolis, MN, USA) at 37˚C. After 
72 h, the non-adherent cells were discarded, and half medium 
change was performed twice a week. When the adherent 
MSCs grew to >80% confluence, they were detached with 
0.05% trypsin/0.53 mmol/l EDTA (Sigma Diagnostics), and 
inoculated at 5x103 cells/cm2 in 3 or 4 fresh tissue culture flasks.
Induction of differentiation of human BMSCs into OBs. When 
the MSCs at passage 3 achieved close to 60% confluence, the 
L-DMEM medium was discarded and replaced with osteo-
genic medium (F12 medium containing 10% FBS, 10-8 mol/l 
dexamethasone, 50 µg/ml ascorbic acid and 10 mmol/l 
β-sodium glycerol phosphate) to induce MSC differentiation 
into OBs. After 10 days of half changing the medium daily, the 
F12 medium was removed and was replaced with L-DMEM 
medium again. The osteogenic differentiation of the MSCs 
was assessed by alkaline phosphatase (ALP) staining, Alizarin 
Red S staining and by the analyses of the expression of type I 
collagen and osteocalcin. 
ALP staining. ALP staining was performed using the Gomori 
modified calcium-cobalt method, as previously described (23). 
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Briefly, the cells were fixed with a solution of 95% alcohol 
for 10 min, and then incubated with ALP at 37˚C for 4 to 6 h. 
Subsequently, the cells were stained with solutions of 2% cobalt 
nitrate and 1% ammonium sulfide. After being air-dried, the 
cells on slides were mounted and observed under a light micro-
scope (Olympus BX51, Olympus, Tokyo, Japan). Cells that 
were positive for ALP were stained a brown or tan color.
Alizarin Red S staining. Alizarin Red S staining was used 
to detect any calcified nodules in the cells, as previously 
described (24). The cells were fixed with 90% ethanol at room 
temperature for 1 h and stained with 40 mmol/l Alizarin Red S 
(Sigma) (pH 4.2) for 30 min. The mineralized nodules were 
observed under a light microscope (Olympus BX51, Olympus).
Immunohistochemistry. The expression levels of type I 
collagen and osteocalcin were detected by immunohis-
tochemistry. The cells on slides were fixed with cold 
acetone for 30 min at room temperature and incubated with 
blocking solution for 30 min at 37˚C. Subsequently, the 
slides were incubated with primary antibodies specific for 
type I collagen (Cat. no. MAB8887, Millipore, Temecula, 
CA, USA) and osteocalcin (cat. no. sc-74495, Santa Cruz 
Biotechnology, Inc., Santa Cruz, CA, USA) overnight at 
4˚C. The following day, the cells were rinsed with PBS and 
incubated at 37˚C for 40 min in the dark with fluorescein 
isothiocyanate (FITC, green)- or rhodamine (red)-conjugated 
secondary antibodies (Molecular Probes, Carlsbad, CA, 
USA). Furthermore, the nuclei were stained with 5 mg/ml 
DAPI (blue). The stained slides were observed under a laser 
confocal microscope (Olympus Fluoview FV500, Olympus).
Establishment of ex vivo hematopoietic culture systems (3D 
and 2D). The 3D-culture system was established as follows: 
i) The OBs differentiated from the BMSCs for 10 days and the 
BMSCs at passage 3 were harvested and mixed at a ratio of 1:1 
to act as seed cells. ii) Bio-derived bone blocks were soaked in 
L-DMEM for 2 days and then in FBS for 2 h before seeding 
the cells to facilitate cell adherence. iii) The mixture of BMSCs 
and OBs (1:1) was suspended into 8x106 cells/ml in 20 µl fresh 
L-DMEM and carefully dripped into prepared bone blocks 
to avoid overflow followed by being incubation at 37˚C with 
5% CO2 in an incubator for 4 h to allow cell adherence. The 
bone blocks were then completely immersed in the L-DMEM 
medium supplemented with 10% FBS, 100 U/ml penicillin, 
100 µg/ml streptomycin, 0.29 mg/ml L-glutamine and 3 mg/ml 
HEPES buffer. They were then grown to confluence for 7-10 days 
and treated with 60Co gamma irradiation for 10 min (25 Gy). 
A 3D-culture system with only MSCs or OBs differentiated 
from BMSCs as seed cells was designed as the experimental 
control group, respectively. In addition, an irradiated (25 Gy) 
mixture of cells (5x104 cells) was seeded and cultured in a 
24-well plate to build the 2D system. In total, we used 4 culture 
systems (2D-Mix, 3D-OB, 3D-MSC and 3D-Mix).
Cultivation of purified CD34+ cells from human umbilical cord 
blood (UCB) in the 3D or 2D culture system. Human UCB cells 
were obtained from mothers at the end of full-term deliveries 
at Sichuan Provincial People's Hospital after obtaining written 
informed consent and the approval of the Institutional Review 
Board of Sichuan Provincial Hospital. The UCB samples was 
incubated with 0.5% (w/v) methyl cellulose dissolved in Hanks' 
solution at room temperature for 30 min to sedimentate the 
UCB red blood cells before the MNCs were collected by Ficoll-
Paque centrifugation and the CD34+ cells were then enriched 
from the MNCs by using immune-magnetic beads (EasySep 
CD34 positive selection kit) and suspended in 20 µl Myelo-
Cult H5100 medium (both from StemCell Technologies Inc., 
Vancouver, BC, Canada) followed by being seeded into the 3D 
or 2D culture system and cultured with Myelo-Cult medium 
containing 1 µM freshly dissolved hydrocortisone without 
exogenous cytokines. After 2 weeks of co-culture, the bone 
blocks were vigorously washed 3 times with phosphate-buff-
ered saline (PBS) to collect the non-adherent cells, and then 
enzymatically dissociated with 0.125% trypsin (0.78 mmol/l 
EDTA) followed by being pipetted and centrifuged at 300 x g 
for 15 min to harvest the adherent cells. Cells in the 2D culture 
system were also collected by trypsin digestion and centrifuga-
tion after 2 weeks of co-culture. The CD34+ cells from each 
culture system were subjected to various phenotypic and func-
tional assays as described below.
Hoechst 33342/propidium iodide (PI) fluorescent staining. 
After 2 weeks of HSPC culture, the CD34+ cells were washed 
off and the bone blocks were transferred to a 24-well culture 
plate followed by the addition of Hoechst (10 µg/ml). The 
24-well culture plate was incubated at 37˚C for 10 min and 
then PI (10 µl/ml) was added. After 20 min of incubation 
at 4˚C, the 24-well plate was taken out of the freezer before 
the bone blocks were observed under a fluorescence micro-
scope (Olympus IX71, Olympus) to identify the viable/dead 
cells attached on the trabecular bone. The cells in the 2D culture 
system were also stained and observed under a fluorescence 
microscope as a control.
Quantitative PCR (qPCR). qPCR was performed for the 
detection of the mRNA expression of cyclin-dependent kinase 
inhibitor 1A (CDKN1A, p21) using DNA-binding SYBR-Green 
dye (Applied Biosystems, Foster City, CA, USA) for the 
detection of the PCR products. The primers used were as 
follows: p21 forward, 5'-GGAAGACCATGTGGACCTGT-3' 
and reverse, 5'-GGCGTTTGGAGTGG TAGAAA-3'; β-actin 
(internal reference) forward, 5'-GCAAGCAGGAGTATG 
ACGAG-3' and reverse, 5'-CAAATAAAGCCATGCCAATC-3', 
which were purchased from Applied Biosystems. The cycling 
conditions were as follows: an initial denaturation at 95˚C for 
15 min, followed by 50 cycles of denaturation at 94˚C for 
15 sec, annealing at 55˚C for 15 sec, and extension at 72˚C for 
15 sec. The β-actin gene was used as a reference. The assay 
was replicated in 3 independent experiments.
Flow cytometry (FCM). To assess the percentage of HSPCs 
remaining in the 2D or 3D culture system before and after 
each culture, FCM was performed to analyze the immuno-
phenotypes of CD34 and CD38. Briefly, a total of 5x105 test 
cells was suspended in 50 µl PBS and stained with 10 µg/ml 
of purified mouse anti-human CD34/CD38 antibody (FcR) 
(Cat. no. 550760; Becton-Dickinson, Mountain View, CA, 
USA) at 4˚C for 30 min. The replicate sample incubated with 
isotype-matched antibodies was used as a control. Dead cells 
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were eliminated by staining with 7AAD. After the cells were 
washed twice in the same buffer, a minimum of 2x104 events 
of each sample was analyzed on a FACS cell sorter using Cell 
Quest software (Becton-Dickinson).
Colony-forming unit (CFU) assay and morphological exami-
nation. The colony-forming assay was performed to assess 
the colony-forming ability of the cells. Briefly, the CD34+ 
cells from the initial UCB samples or the cultured cells were 
incubated in methylcellulose medium with recombinant cyto-
kines (MethoCult GF+ H4435; StemCell Technologies Inc.) 
at 2x103 in 35-mm tissue culture dishes (Costar, Lowell, MA, 
USA). The dishes were incubated at 37˚C in a humidified 
atmosphere with 50 ml/l CO2 in air. All cultures were carried 
out in triplicate. After 14 days of culture, colonies belonging 
to burst-forming unit-erythroid (BFU-E), colony-forming 
unit-granulocyte/macrophage (CFU-GM), colony-forming 
unit-macrophage (CFU-M) and colony forming unit-granu-
locyte/erythroid/macrophage/megakaryocyte (CFU-GEMM) 
consisting of ≥50 cells were scored under an inverted micro-
scope (Olympus IX81, Olympus). To assess the accuracy of 
in situ identification, individual colonies were selected and 
stained with Wright's staining (Merck, Darmstadt, Germany) 
for the morphological identification of cells.
Long-term culture initiating cell (LTC-IC) assay. A modified 
LTC-IC assay was performed as previously described (25). 
Briefly, irradiated (80 Gy) mouse bone marrow stromal cells 
(M2-10B4, American Type Culture Collection, Rockville, MD, 
USA) were seeded at 105 cells/well in 96-well flat-bottomed 
plates as a feeder layer. CD34+ cell subpopulations purified 
from UCB or those isolated from cultured cells by sorting with 
a FACSVantage (Becton-Dickinson) were seeded at a limiting 
dilution on the feeder layer in serum-containing medium. 
For each evaluation, at least 3 cell concentrations were used 
with 24 replicates per concentration. The plates were incu-
bated at 37˚C, 5% CO2 with weekly half medium exchanges. 
After 5 weeks of culture, the cells were harvested and 
transferred to methylcellulose medium with recombinant cyto-
kines (MethoCultGFt H4434V; StemCell Technologies Inc.) 
for colony-forming assays. After 14 days of culture, colonies 
with >50 cells were counted to assess LTC-IC activities and we 
calculate the frequency of LTC-IC according to the manufac-
turer's instructions (StemCell Technologies Inc.).
NOD/SCID repopulating cell (SRC) assay. Human cord 
blood CD34+ cells were cultured for 14 days in 4 culture 
systems (2D-Mix, 3D-OB, 3D-MSC and 3D-Mix). The cells 
were harvested, suspended in 1 ml α-MEM and injected 
intravenously via the tail vein into 8-week-old, sub-lethally-
irradiated (2.5 Gy) NOD/SCID mice (n=40; Central Institute 
for Experimental Animals, Institutes for Biological Sciences, 
Shanghai, China). This animal experiment was approved by the 
Institutional Animal Care and Use Committee of the Sichuan 
Provincial People's Hospital. Each mouse received cells equiv-
alent to 104 CD34+ cells together with irradiated (15 Gy using 
a 60Co γ-irradiator) non-repopulating CD34- cells as accessory 
cells. The recipients were sacrificed by carbon dioxide asphyxi-
ation 8 weeks following transplantation, and bone marrow 
MNCs were harvested by Ficoll density gradient centrifugation 
and stained with FITC-labeled anti-human CD45 antibody 
to analyze for the presence of human CD45+ cells by FCM. 
Mice were considered positive for human HSC engraftment 
when at least 0.1% CD45+ human cells were detected in the 
mouse bone marrow cells. The SRC frequency was calcu-
lated based on the Poission distribution using the equation 
Pi = e(-N) x (Ni/i!) at P0, as previously described (26,27). 
PCR analysis using human specific 17α-satellite gene expres-
sion (17α-satellite, 5'-ACGGGATAACTGCACCTAAC-3'; 
5'-CCATAGGAGGGTTCAACTCT-3') was performed to 
confirm the FCM results.
Εnzyme-linked immunosorbent assay (ELISA). After 2 weeks 
of HSPC culture, the media from 4 culture systems were 
clarified at 3,500 rpm for 5 min, and the supernatants were 
subjected to quantitative ELISA for the secreted fibronectin, 
collagen IV, vitronectin and laminin using commercially avail-
able fibronectin, collagen IV, vitronectin and laminin ELISA 
kits (RayBiotech Inc., Norcross, GA, USA) according to the 
manufacturer's instructions.
Western blot analysis. The MSCs and OBs in the 4 culture 
systems were harvested, washed twice in cold 1X PBS (Gibco, 
Invitrogen), and subsequently lysed in ice-cold RIPA lysis 
buffer [50 mmol/l Tris-HCl (pH 8.0), 150 mmol/l NaCl, 0.1% SDS, 
1% NP-40, 0.25% sodium deoxycholate and 1 mmol/l EDTA] 
with freshly added protease inhibitor cocktail (Calbiochem, 
Shanghai, China). After 30 min of lysis on ice, the cell lysates 
were cleared by centrifugation at 12,000 x g, and the protein 
concentration was measured using the BCA Protein assay 
kit (Pierce, Pittsburgh, PA, USA). Equal amounts of the protein 
samples were subjected to 10% sodium dodecyl sulfate-poly-
acrylamide gel electrophoresis (SDS/PAGE) and blotted onto 
PVDF membranes (GE Healthcare Biosciences, Piscataway, 
NJ, USA). The membranes were blocked with PBS-T containing 
5% non-fat dry milk and incubated with anti-angiopoietin-1 
(cat. no. ab76956; Abcam, Cambridge, MA), anti-osteopontin 
(cat. no. sc-10591; Santa Cruz Biotechnology, Inc.), anti-stem 
cell factor (SCF; cat. no. ab52603), CXCL12 (cat. no. ab25117), 
RUNX2 (cat. no. ab76956) (all 3 from Abcam, Cambridge, 
MA, USA) and anti-glyceraldehyde 3-phosphate dehydroge-
nase (GAPDH) (cat. no. sc-5565; Santa Cruz Biotechnology, 
Inc.) antibodies. Membrane-bound first-step antibodies were 
reacted with horseradish peroxidase (HRP)-conjugated 
secondary antibody (Sigma). The bands were visualized 
with enhanced chemiluminescence (Millipore, Billerica, 
MA, USA). Protein bands were quantified using ImageJ soft-
ware 1.43 (NIH, Bethesda, MD, USA) and normalized to the 
levels of GAPDH (loading control).
Statistical analysis. The data were presented as the means and 
standard error. Statistical comparisons were performed using 
the two-sided Student's t-test. Values of p<0.05 and p<0.01 
were considered to indicate statistically significant differences.
Results
HSCs derived from 3D culture system exhibit a morphological 
characterization similar to the HSC niche. It is now clear that 
MSCs and OBs are two crucial components of the HSC niche 
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in adult bone marrow. Thus, we selected a mixture of MSCs 
and OB-like cells differentiated from MSCs to mimic the HSC 
niche and to build an HSC in vitro culture system in our study. 
Our primary MSCs were derived from the bone marrow of 
healthy adults, and were then differentiated into OB-like cells 
by culture in osteogenic medium for 10 days (Fig. 1B and C). 
We then performed morphological and histological analyses 
of the MSCs differentiated into OBs. Our results revealed 
that the OB-like cells differentiated from the MSCs were a 
heterogeneous population, as evidenced by asynchronous 
differentiation and the dynamic expression of osteogenic 
markers, including ALP, type I collagen, osteocalcin and 
calcium nodules (Fig. 1D-G).
Since the BDBS material was derived from human long 
bone (femurs) where adult hematopoietic tissues are mainly 
located, they thus supplied a spatial structure very similar to 
the HSC niche. Our study demonstrated an excellent biocom-
patibility of the bio-derived bone with human BMSCs and OBs 
differentiated from MSCs in vitro. After seeding the BMSCs 
and OBs differentiated from MSCs into the bio-derived bone 
for 7-10 days, the cells grew along with the inner surfaces of 
bone trabecular pores and formed a stable fibrous 3D structure. 
As shown by scanning electron and inverted microscopy, the 
cells tightly attached to the surface of the trabecular bone and 
secreted an amount of extracellular matrix (ECM) components 
which appeared elliptical with pseudopodal extensions and 
filled the intertrabecular cavity of cancellous bone (Fig. 2A-D). 
These features indicated a ‘biomimetic HSC niche’ with BDBS 
as a 3D scaffold, and a mixture of MSCs and OB-like cells 
as HSCs. Compared to the 3D culture system, the mixture of 
MSCs and OB-like cells in the 2D system was flat in shape and 
produced a lower amount of ECM components (Fig. 1A).
In order to determine whether the 3D-Mix system is able to 
supply a long-term culture of HSC in vitro, the frequency of live 
and dead feeder cells (MSCs and OB-like cells) on trabecular 
bone of BDBS after 2 weeks of HSPC culture was investigated 
by Hoechst 33342/PI fluorescent staining (Fig. 2E-F). It was 
shown that feeder cell death was 8.1% in the 3D-Mix culture 
system, whereas feeder cell death in the 2D-Mix culture system 
reached 17.3% after 2 weeks (data not shown).
3D-Mix of MSCs and OB differentiated from MSCs provide a 
microenvironment closely similar to the HSC niche. It is known 
that the bone marrow niche plays key roles in the self-renewal, 
survival, and maintenance of HSCs by expressing many crucial 
molecules, including chemokines, growth factors, cell-surface 
and adhesion molecules (28). Thus, in this study, we examined 
the protein expression of angiopoietin-1, RUNX2, CXCL12, 
osteopontin and SCF, which are genes that control HSC proper-
ties, in our 2D and 3D culture system. The results of western 
blot analysis revealed that all these genes were highly expressed 
in the 3D-Mix, despite the fact that the expression of individual 
genes was slightly lower than or close to that of the other 
culture systems, such as the expression of osteopontin in the 
3D-OB (was higher), and that of CXCL12 in the 3D-MSC (was 
higher) systems. These findings implied that the interactions 
of human BMSCs and OBs in the 3D-Mix may contribute to 
a more comprehensive and balanced expression of cytokines, 
Figure 1. Osteoblasts differentiated from human marrow mesenchymal stromal cells (MSCs). (A) Morphology of HSPCs in the 2D system. The mixture of 
MSCs and osteoblasts (OBs) induced from the bone marrow-derived MSCs (BMSCs) as seed cells was seeded in a 24-well plate to build the 2D system in which 
the HSPCs were cultured for 2 weeks (x200 magnification). (B) Morphology of human MSCs of the first generation (x200 magnification); (C) morphology of 
osteoblasts differentiated from MSCs after 10 days (x40 magnification); (D) Gomori staining for alkaline phosphatase (ALP) expression in osteoblasts after 8 days 
(x200 magnification); (E) assay for osteocalcin expression with rhodamine-conjugated monoclonal antibody after 14 days (x400 magnification); (F) assay for col-
lagen I by immunohistochemistry after 10 days (x100 magnification); (G) Alizarin S staining for mineralized nodule formation after 21 days (x100 magnification).
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which likely more closely resembles the physiological state of 
the HSC niche and is more beneficial to HSPC in vitro culture 
compared with the other culture systems (Fig. 3A).
The HSC microenvironment is enriched with ECM proteins, 
such as fibronectin, collagen IV, vitronectin and laminin, which 
are an essential part of the HSC niche (29). Thus, in this study, 
the culture systems were subjected to ELISA to determine 
the presence of these molecules. It was observed that all these 
ECM molecules were highly expressed at the protein level in 
the 3D-Mix, although the levels of individual ECM molecules, 
such as laminin and collagen IV were slightly lower than or 
similar to those in the 3D-MSC system (Fig. 3B-E). These find-
ings indicated that the interactions of human BMSCs and OBs 
in the 3D-Mix provided most comprehensive ECM protein 
amounts to support and modulate HSPCs in vitro, compared to 
the other 3 systems.
Abundant growth of CD34+ cells in the 3D-Mix system. It 
is known that CD34 positivity is used as the most common 
immune phenotype for human HSPCs, and CD34+CD38- cells 
are regarded as the more primitive cell subpopulation. After 
2 weeks of HSPC culture in the 3D or 2D system, the cells 
were harvested and subjected to FCM to count the number 
of CD34+ cells, CD34+CD38- cells representing long-term 
repopulating cells (LTRCs) and CD34+CD38+ cells repre-
senting short-term repopulating cells (STRCs) in these 
systems (Fig. 4A). It was observed that the levels of expansion in 
the total CD34+ cell numbers in the 3D-Mix were significantly 
higher (p<0.05), compared to the other 3 systems (3D-MSC, 
3D-OB and 2D-Mix). The yield of CD34+CD38- cells in the 
3D-Mix was significantly higher than that in the 3D-OB 
and 2D-Mix, although there was no statistically significant 
difference compared with the 3D-MSC system. Moreover, the 
expansion of CD34+CD38+ cells in the 3D-Mix was also signif-
icantly improved when compared to that in the 3D-MSC and 
2D-Mix (p<0.05), although the number of CD34+CD38+ cells 
in the 3D-Mix was only slightly higher than that of the 3D-OB 
system (Table I). Overall, these findings indicated that the 
Figure 2. The cells grew after seeding human bone marrow stromal cells (BMSCs) and osteoblasts differentiated from mesenchymal stromal cells (MSCs) onto 
bio-derived bone for 7-10 days. (A and B) Human BMSCs and osteoblasts differentiated from MSCs on human bio-derived bone scaffolds examined under 
an inverted microscope after 10 days [(A) x100 magnification; (B) x200 magnification]; (C and D) human BMSCs and osteoblasts differentiated from MSCs 
on human bio-derived bone scaffolds examined under a scanning electron microscope after 10 days [(C and D) x1,000 magnification; arrows indicate ECM 
components]; (E and F) Hoechst 33342/propidium iodide (PI) fluorescent staining to examine the frequency of live and dead feeder cells on trabecular bone of 
bio-derived bone scaffolds after 2 weeks of HSPC culture. (E) Observation under an inverted microscope; (F) observation under a fluorescence microscope. Blue 
indicates the live cells and red indicates the dead cells.
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3D-Mix culture system had the advantages of both the 3D-OB 
and 3D-MSC systems, in that it did not only expand the total 
number of CD34+ haematopoietic cells, but also maintained 
these primitive cells in vitro.
A large proportion of HSCs is known to be in a quiescent 
state in the bone marrow niche (9). It was not apparent whether 
HSCs in this state enter the cell cycle at all. In this study, in 
order to address this issue, HSPCs from the culture systems 
were subjected to qPCR assay to determine the expression 
of p21, which is an essential regulator of the quiescence of 
HSCs (30). Our results revealed that p21 expression in the 
HSCs from the 3D-Mix system was significantly higher than 
that in the HSCs from the other culture systems, particularly 
in comparison with the 3D-OB and 2D-Mix systems, indi-
cating that a large percentage of HSCs from the 3D-Mix was 
maintained in the G0 stage of the cell cycle. This suggested 
that the 3D-Mix possessed the ability to foster a large pool 
of quiescent HSCs, which is a critical niche characteristic 
in vivo (Fig. 4B).
3D-Mix system provides superior support for active multi-
lineage hematopoiesis. Cultured CD34+ cells from the systems 
were also subjected to in vitro CFU assays to evaluate the 
proliferation and differentiation potential of hematopoietic 
progenitor cells. The CD34+ cells were sorted after 2 weeks 
of culture to avoid contamination with other cells and we 
performed methylcellulose assay to determine their potential 
clonal growth as, CFU-GEMM (termed CFU-MIX), CFU-GM 
and BFU-E. Colony formation assays revealed a significantly 
higher output of progenitors from the 3D-Mix compared to the 
other 3 culture systems (p<0.001). The distribution of CFUs 
was analyzed using an inverted microscope to observe the 
colony morphology, showing a significantly higher number of 
BFU-E in the 3D-Mix compared to the other 3 culture systems. 
Moreover, the frequencies of CFU-GM and CFU-MIX in the 
3D-Mix were similar to those in the 3D-MSC and 3D-OB 
systems, respectively (Fig. 4C).
In parallel to the experiment on committed progeni-
tors, we also examined the effects of the 3D-Mix on more 
primitive progenitors, as measured using the in vitro LTC-IC 
assay. CD34+ cells generated in the 4 culture systems were 
subjected to in vitro LTC-IC assay to determine whether they 
could preserve the ability to sustain long-term hematopoiesis. 
Following the initial 14-day culture period in the 4 culture 
systems, the output of CD34+ cells was plated on M2-10B4 for 
5 weeks and then cultured in methylcellulose to analyze the 
LTC-IC-derived colony-forming cells. It was observed that the 
LTC-IC frequency in the 3D-Mix system was higher than that 
of the other 3 systems (Fig. 4D).
Human cord blood CD34+ cells were cultured for 14 days 
in the 4 culture systems. The cells were harvested, washed and 
injected into sublethally irradiated (2.5 Gy) NOD/SCID mice; 
Figure 3. 3D-Mix of mesenchymal stromal cells (MSCs) and osteoblasts differentiated from MSCs supply a closely similar microenvironment. (A) Western blot 
analysis revealed the expression of angiopoietin-1, RUNX2, CXCL12, osteopontin and stem cell factor (SCF) in the 4 culture systems. (B-E) ELISA confirmed the 
expression of extracellular matrix proteins, such as fibronectin, collagen IV, vitronectin and laminin in the 4 culture systems. *p<0.05 compared with 3D-Mix system.
Table I. Umbilical cord blood HSC expansion over 7 days of culture.
Group 3D-Mix 3D-MSC 3D-OB 2D-Mix
CD34+ cells 14.86±3.74 7.69±1.67a 11.52±4.58a 2.63±1.17a
CD34+CD38- cells 5.42±1.07 4.96±1.44 1.52±0.53a 0.57±0.16a
CD34+CD38+ cells 12.65±4.42 6.36±2.07a 10.87±5.33 2.09±1.35a
ap<0.05 compared with 3D-Mix system. HSCs, hematopoietic stem cells.
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each mouse received cells equivalent to 104 starting CD34+ cells. 
At 8 weeks post-cell transplantation, bone marrow cells were 
harvested from the recipients and subjected to FCM with an 
anti-human CD45 antibody. Mice were considered positive for 
human HSC engraftment when at least 0.1% CD45+ human cells 
were detected in the mouse bone marrow cells. Bone marrow 
cells from positive mice were further analyzed by FCM using 
antibodies for human CD33 and CD34 antigens (Fig. 5A). We 
calculated the SRC concentration using the Poisson probability 
at P0. In our experiments, the positivity of human HSC engraft-
ment in the 3D-Mix system were found to be the highest out of 
the 4 culture systems and cord blood CD34+ cells cultured in 
Figure 4. CD34+ cells in the 4 culture systems. (A) Flow cytometric analysis was used to count the number of CD34+ cells, CD34+CD38- cells and CD34+CD38+ cells 
at 14 days; (B) qPCR assay was used to determine the expression of p21; (C) colony formation assays; (D) CD34+ cells generated in the 4 culture systems were 
subjected to in vitro long term culture initiating cell (LTC-IC) assays to determine whether they could preserve the ability to sustain long-term hematopoiesis. 
*p<0.05 compared with 3D-Mix system.
Figure 5. Determination of human hematopoietic reconstitution in NOD/SCID mice 8 weeks post-transplantation. (A) Transplantated bone marrow cells 
belonging to the 3D-Mix system from the mice were subjected to flow cytometric analysis; (B) PCR analysis of 17α-satellite gene expression demonstrated the 
presence of human hematopoietic cells in the bone marrow of NOD/SCID mice.
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the 3D-Mix system were observed to have significantly higher 
SRC frequencies than the cells cultured in the other 3 systems 
(p<0.01; Table II). Furthermore, PCR analysis of 17α-satellite 
gene expression revealed the presence of human hematopoietic 
cells in the bone marrow of the NOD/SCID mice (Fig. 5B).
Discussion
An ideal HSPC culture system should possess both the char-
acteristics of the long-term maintenance of the HSC pool and 
the continuousy promoting effects on the proliferation of the 
hematopoietic progenitor pool. However, the method with 
which to achieve this apparently contradictory and dynamic 
process in vitro continues to be an intriguing issue in HSPC 
culture research (1). To date, there is still not a suitable HSPC 
culture system to provide a suitable platform with which to 
study cellular biology and to be used in clinical practice by 
helping to achieve steady-state hematopoiesis in vivo. Although 
cytokine-driven culture which is supplemented with cytokines, 
such as fetal liver tyrosine kinase-3 ligand (FLT3-L), SCF, 
interleukin-3 (IL-3) and thrombopoietin (TPO) has been 
demonstrated to effectively promote expansion, it is difficult 
to maintain long-term HSPC culture due to the rapid onset of 
differentiation and the rapid loss of multipotency in culture, 
which thus renders this system insufficient for the clinical appli-
cations of these cells. By contrast, HSCs efficiently self-renew 
in their natural microenvironment (known as the HSC niche) 
in the bone marrow (31). Recently, studies have indicated that 
the HSC niche is responsible for HSC fate and have clarified 
the important regulatory component of the HSC niche (32-34). 
Therefore, closely mimicking the bone marrow niche ex vivo is 
considered to be an effective means of developing novel culture 
strategies to specifically regulate the balance of HSPC self-
renewal and proliferation. Studies have proven that this method 
is very effective (19,35,36). With the in-depth understanding of 
the complex HSC niche, we further improved the HSPC culture 
protocol based on our previous study, which was demonstrated 
to initially have both properties of maintaining a certain 
number of the stem cell pool and continuously promoting the 
proliferation of progenitors, compared with other traditional 
culture systems. The HSC niche is an in vivo regulatory micro-
environment where HSCs reside and maintain their capability 
of self-renewal and multipotency, and is composed of all 
types of cellular and humoral factors. OBs and BMSCs have 
long been revealed to be the two major crucial components of 
the HSC niche in bone marrow to support the maintenance, 
proliferation and differentiation of HSCs. OBs are derived from 
the MSCs in bone marrow. Namely, when MSCs commit to 
osteogenesis, they differentiate into osteoprogenitors that prog-
ress into pre-osteoblasts, OBs, and finally into osteocytes that 
mineralize and form bone (37). Actually, the osteoblastic niche 
has been proven to include osteoprogenitor cells, quiescent bone 
lining cells and active OBs (12). Sacchetti et al demonstrated 
that human CD45-CD146+ osteoprogenitor cells were able to 
transfer hematopoietic activity to an ectopic site (38). It was 
found that the deletion of OBs under the control of collagen a1 
type I promoter led to a decrease in the numbers of HSCs (39). 
That was why we selected the OBs differentiated from human 
BMSCs to act as a candidate of feeder cells in this study, instead 
of directly using a mature OB cell line. Our experiments of 
the induction of the differentiation of human BMSCs to OBs 
indicated that the MSCs that differentiated into OBs were a 
heterogeneous population at various stages of differentiation, 
rather than just fully mature OBs. MSCs express high levels 
of HSC maintenance factor transcripts, including CXCL12, 
angiopoietin-1, SCF, IL-7 and osteopontin. Méndez-Ferrer et al 
identified a nestin-expressing MSC population (nestin+ MSC) 
that is closely associated with putative HSCs. The depletion of 
nestin+ MSCs by the inducible expression of diphtheriatoxin 
receptor in nestin-expressing cells caused the mobilization of 
50% of HSCs to the spleen (40). In addition, in another study, 
the homing of transplanted progenitor cells into MSC-depleted 
recipients was shown to be reduced by 90% (41). Recently, 
Omatsu et al found that CAR cells are important in supporting 
the proliferation of HSPCs. Further data confirmed that CAR 
cells which express osteogenic and adipogenic genes are a 
form of osteogenic-adipo progenitor derived from MSCs (42). 
Therefore, in this study, we selected chose human BMSCs 
as the other candidate of feeder cells in our culture system. 
In order to more closely mimic a multi-cell state in the HSC 
niche to produce synergistic control of the balance between 
quiescence, self-renewal and proliferation in the HSPC culture 
system, we co-cultured BMSCs and OBs differentiated from 
MSCs without any cytokines in this study to create a novel 
culture system to support the maintenance and proliferation of 
HSPCs in vitro.
In order to mimic the physical conditions of the HSC niche, 
many groups have tested different materials as scaffolds to 
build a 3D culture system, which include natural materials, 
such as cellulose porous microspheres and collagen carriers, 
or synthetic materials, such as macroporous PEG hydrogels, 
porous biomatrix, porous polyvinyl formal resin, polyethylene 
terephthalate, colloidal crystals and porous gelatin micro-
spheres (13-15,43,44). In this study, we adopted bio-derived 
bone made from human femurs as a system scaffold which 
preserves the natural spongy architecture of trabecular bone 
to more closely mimic the HSC niche in vivo. This study 
demonstrated that the BDBS had good biocompatibility and 
more importantly, partially reserved calcium, phosphonium 
and other ECM proteins, which have been proven to promote 
the osteogenic differentiation of MSCs in vitro. It is known 
that 3D cultures allow the reconstruction of the complex 
tissue architecture, thus providing a better platform with 
which to study cellular biology. There is evidence to indicate 
that 3D culture systems are superior to traditional 2D systems 
as regards the maintenance and expansion of HSPCs, which 
Table II. Expansion of SRCs in the 3D-Mix culture system.
Culture   SRC
system Positive/total % Positive frequency
3D-Mix 8/10 80 1 in 5832
3D-MSC 7/10 70a 1 in 7901a
3D-OB 5/10 50a 1 in 10745a
2D-Mix 3/10 30a 1 in 16227a
ap<0.05 compared with 3D-Mix system. SRC, SCID repopulating cell.
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proves that the spatial architecture is one of the most important 
physiological conditions in the stem cell niche and influences 
the biological behavior of HSCs (37,45-47). The natural scale 
and pore size of bio-derived bone as a scaffold are close to the 
natural architecture of the HSC niche in vivo. In this study, the 
mixture of human BMSCs and OBs differentiated from MSCs 
attached to this natural scaffold very well (70-80% attach-
ment) (data not shown). These two cell populations were 
observed to grow in the porous network of trabecular bone and 
form a meshwork-like structure, while the HSCs embedded and 
grew in the intercellular spaces. 3D-MSC and 3D-OB systems 
are used as controls apart from the traditional 2D culture 
system (10,19,20). We carried out extensive analyses of special-
ized microenvironments that were recognized by hematopoietic 
CD34+ cells in the 3D culture system. The HSC niche is known 
to express many crucial molecules, which include chemokines, 
growth factors, cell-surface and adhesion molecules, and plays 
key roles in HSC self-renewal, survival and maintenance (28). 
Furthermore, the majority of the secreted factors which have 
been proposed to control HSC fate, such as angiopoietin-1, 
RUNX2, CXCL12, osteopontin and SCF are supplied by MSCs 
and OBs in the HSC niche (48). We found that the interactions of 
human BMSCs and OBs in the 3D-Mix system may contribute 
to a more comprehensive and balanced expression of cytokines, 
which more closely mimics the physiological state of the HSC 
niche and is more beneficial to HSPC culture in vitro compared 
with the other culture systems. The HSC microenvironment is 
enriched with ECM proteins, such as fibronectin, collagen IV, 
vitronectin and laminin, which are an essential part of the HSC 
niche (29). Thus, in this study, the culture systems were subjected 
to ELISA to determine the presence of these molecules. High 
levels of ECM molecules were found to be secreted by the 
MSCs and OBs differentiated from MSCs and deposited on 
the surface of the two cell populations, which means that they 
themselves were capable of adding a physiologically relevant 
dimension to the culture system. In addition, our data indicated 
that the interactions of human BMSCs and OBs in the 3D-Mix 
system provided a comprehensive amount of ECM proteins to 
support and modulate HSPC culture in vitro.
In the present study, phenotypic analysis of expanded cells 
by FCM revealed that the proportion of CD34+CD38- cells 
representing LTRC in the 3D-Mix system was significantly 
higher than that in the 3D-OB system, although there was no 
statistically significant difference in the yield of CD34+CD38+ 
cells (which represent STRCs) between them, which implies 
that MSCs play an important role in maintaining the quies-
cence HSCs in vitro. On the other hand, although half of the 
OBs in the 3D-OB system was replaced by human BMSCs in 
the 3D-Mix system, the number of CD34+CD38+ cells between 
the two culture systems exhibited no obvious difference, which 
implies that the interaction of MSCs with OBs also has an 
effect on promoting HPC proliferation in vitro. We also found 
that the yield of CD34+CD38+ cells from the 3D-Mix culture 
system was significantly higher than that from the 3D-MSC 
system, although the number of CD34+CD38- cells was 
slightly lower than that from the 3D-MSC system, indicating 
tht OBs differentiated from human BMSCs play a critical 
role in improving the proliferation of HSPCs in vitro. On the 
other hand, although half of the MSCs in the 3D-MSC system 
was replaced by OBs in the 3D-Mix system, the number of 
CD34+CD38- cells in the 3D-Mix was close to that in the 
3D-MSC system, which implies that the interaction of OBs 
with MSCs also has the effect of promoting HSC self-renewal 
in vitro.
PCR analysis of p21, which is an essential regulator of the 
quiescence of HSCs, also confirmed the FCM results, which 
showed that p21 expression in the HSCs from the 3D-Mix 
system was significantly higher than that in the cells from 
the 3D-OB system and very close to that in the cells from the 
3D-MSC system, indicating that a large percentage of HSCs 
from the 3D-Mix system was maintained in the G0 stage of the 
cell cycle. It is known that UCB LTC-ICs are present among 
the CD34+CD38- cell fraction and LTC-IC assays exhibit 
multilineage differentiation ability and major proliferative 
potential, which is regarded as a functional measure of self-
renewal (47). Our results demonstrated that the frequency of 
LTC-ICs from the 3D-Mix system was statistically higher than 
that of the other 3 culture systems, particularly the 3D-OB and 
2D-Mix systems, which demonstrated that the 3D-Mix system 
contained a higher number of more primitive hematopoietic 
cells ex vivo compared with the other 3 systems, possessing the 
important ability of fostering a large pool of quiescent HSCs, 
which is a critical niche characteristic in vivo. In the SRC assay, 
which indicated the reconstituting ability of these cultured 
cells, the difference in the percentage of chimerism of human 
CD45+ cells among bone marrow cells of mice transplanted 
with cultured cells strongly suggested that the 3D-Mix more 
effectively supported ex vivo-generated HSCs with the ability 
to sustain and reconstitute long-term human hematopoiesis 
in vivo, compared with the other 3 systems.
In conclusion, our data demonstrate that the 3D culture 
system, established by the co-culture of BMSCs and OBs 
differentiated from MSCs on human BDBS, is a more compre-
hensive and balanced system, which not only continuously and 
effectively promotes the self-renewal and ex vivo expansion 
of HSPCs, but also maintains a large pool of primitive HPCs 
with superior phenotypic and functional attributes. Compared 
with the other 3 culture systems, the 3D-Mix culture system 
has some features which are more similar to those of the HSC 
niche, namely as regards the maintenance and expansion of 
HSPCs in vitro.
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